Therefore, NEAT1 expression in serum can serve as a potential biomarker for differentiating childhood ITP patients from healthy individuals, in addition to differentiating non-chronic from chronic ITP patients. This evidence concerns the gene NEAT1 and autoimmune thrombocytopenic purpura.